All Stories

  1. highly potential new drug candidates against TB
  2. Synthesis of CNS active thyrotropin-releasing hormone (TRH)-like peptides: Biological evaluation and effect on cognitive impairment induced by cerebral ischemia in mice
  3. ChemInform Abstract: Room Temperature N-Arylation of Amino Acids and Peptides Using Copper(I) and β-Diketone.
  4. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents
  5. Antiplasmodial activity of short peptide-based compounds
  6. Room temperature N-arylation of amino acids and peptides using copper(i) and β-diketone
  7. Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice
  8. Metal-free synthesis of N-fused heterocyclic iodides via C–H functionalization mediated by tert-butylhydroperoxide
  9. ChemInform Abstract: Regiocontrolled Palladium-Catalyzed and Copper-Mediated C-H Bond Functionalization of Protected L-Histidine.
  10. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents
  11. Intestinal transport of TRH analogs through PepT1: the role ofin silicoandin vitromodeling
  12. Synthetically modified l-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformans
  13. Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans
  14. ChemInform Abstract: Palladium-Catalyzed Regioselective C-5 Arylation of Protected L-Histidine: Microwave-Assisted C-H Activation Adjacent to Donor Arm.
  15. Solvent-free peptide synthesis assisted by microwave irradiation: environmentally benign synthesis of bioactive peptides
  16. Synthesis and antimicrobial activities of His(2-aryl)-Arg and Trp-His(2-aryl) classes of dipeptidomimetics
  17. Regiocontrolled palladium-catalyzed and copper-mediated C–H bond functionalization of protectedl-histidine
  18. Palladium-Catalyzed Regioselective C-5 Arylation of Protected l -Histidine: Microwave-Assisted C–H Activation Adjacent to Donor Arm
  19. Microwave-assisted solution phase peptide synthesis in neat water
  20. Rapid microwave-assisted solution-phase peptide synthesis
  21. Mechanistic Insights into PEPT1-Mediated Transport of a Novel Antiepileptic, NP-647
  22. Regiospecific Direct C-H Arylation at the 2-Position of l-Histidine Using Arylboronic Acids
  23. Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: Synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities
  24. Recent Advances in New Structural Classes of Anti-Tuberculosis Agents
  25. Convenient syntheses of bulky group containing imidazolium ionic liquids
  26. Facile Syntheses of Histamine- and Imidazole-4-propionic Acid–Derived Room-Temperature Ionic Liquids
  27. Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia
  28. NP-647, a novel TRH analogue: Investigating physicochemical parameters critical for its oral and parenteral delivery
  29. Synthesis, Receptor Binding, and CNS Pharmacological Studies of New Thyrotropin-Releasing Hormone (TRH) Analogues
  30. Extended side chain analogues of 8-aminoquinolines: Synthesis and evaluation of antiprotozoal, antimicrobial, β-hematin inhibition, and cytotoxic activities
  31. Evidence of the formation of direct covalent adducts of primaquine, 2-tert-butylprimaquine (NP-96) and monohydroxy metabolite of NP-96 with glutathione and N-acetylcysteine
  32. Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines)
  33. ChemInform Abstract: Quinolines and Structurally Related Heterocycles as Antimalarials
  34. CNS safety pharmacology of newer TRH Analog-L-pGlu-(1-benzyl)-L-His-LProNH2
  35. Quinolines and structurally related heterocycles as antimalarials
  36. Structure based design of novel inhibitors for histidinol dehydrogenase from Geotrichum candidum
  37. Development and validation of a sensitive and selective UHPLC–MS/MS method for quantitation of an investigational anti-malarial compound, 2-tert-butylprimaquine (NP-96) in rat plasma, and its application in a preclinical pharmacokinetic study
  38. ChemInform Abstract: Regiospecific Synthesis of 2,3-Disubstituted-L-histidines and Histamines.
  39. ChemInform Abstract: Convenient N-Protection of L-Pyroglutamic Acid Esters.
  40. ChemInform Abstract: Synthesis and Biology of New Thyrotropin-Releasing Hormone (TRH) Analogues.
  41. ChemInform Abstract: Antimalarial Activities of Ring-Substituted Bioimidazoles.
  42. New Antimicrobial Hexapeptides: Synthesis, Antimicrobial Activities, Cytotoxicity, and Mechanistic Studies
  43. 2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization
  44. Atorvastatin Calcium
  45. Discovery of Trp-His and His-Arg Analogues as New Structural Classes of Short Antimicrobial Peptides
  46. Neuropharmacological profile of l-pGlu-(1-benzyl)-l-His-l-ProNH2, a newer thyrotropin-releasing hormone analog: Effects on seizure models, sodium current, cerebral blood flow and behavioral parameters
  47. Antimalarials from nature
  48. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines
  49. ChemInform Abstract: Facile Synthesis of N-α-Boc-1,2-Dialkyl-L-histidines (VI): Utility in the Synthesis of Thyrotropin-Releasing Hormone (TRH) Analogues (VII) and Evaluation of the CNS Activity.
  50. Fexofenadine Hydrochloride
  51. Antiepileptic potential and behavioral profile of l-pGlu-(2-propyl)–l-His–l-ProNH2, a newer thyrotropin-releasing hormone analog
  52. Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
  53. Facile synthesis ofN-α-boc-1,2-dialkyl-l-histidines: Utility in the synthesis of thyrotropin-releasing hormone (trh) analogs and evaluation of the cns activity
  54. Selectivity-based QSAR approach for screening and evaluation of TRH analogs for TRH-R1 and TRH-R2 receptors subtypes
  55. Target-Specific Anti-Fungal Discovery by TargetingGeotrichum candidumHistidinol Dehydrogenase: A Hybrid Approach
  56. ChemInform Abstract: Synthesis and Antituberculosis Activity of 2,4-Disubstituted Quinolines.
  57. ChemInform Abstract: Facile Regiospecific Syntheses of N-α,N-1(τ)-Dialkyl-L-histidines.
  58. Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs)
  59. A highly significant scheme to modify amino acids for novel bioactive peptides.
  60. Synthesis and Evaluation of N-Acetyl-L-tyrosine Based Compounds as PPARα Selective Activators.
  61. Unprecedented 1,1′-Carbonyldiimidazole-Mediated Amidation of Unprotected α-Amino Acids in Water.
  62. Recent Advances in Antimalarial Drug Development
  63. Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators
  64. Unprecedented 1,1′-Carbonyldiimidazole-Mediated Amidation of ­Unprotected α-Amino Acids in Water
  65. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines
  66. Synthesis, antimalarial, antileishmanial, antimicrobial, cytotoxicity, and methemoglobin (MetHB) formation activities of new 8-quinolinamines
  67. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1
  68. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives
  69. Synthesis, receptor binding, and activation studies of N(1)-alkyl-l-histidine containing thyrotropin-releasing hormone (TRH) analogues
  70. Thyrotropin-Releasing Hormone (TRH) Analogues That Exhibit Selectivity to TRH Receptor Subtype 2.
  71. Current Advances in Antifungal Targets and Drug Development
  72. Current Status of Target-Based Antimycobacterial Natural Products
  73. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents
  74. Recent advances in antimalarial drug development
  75. Thyrotropin-Releasing Hormone (TRH) Analogues That Exhibit Selectivity to TRH Receptor Subtype 2
  76. Recent Advances in New Structural Classes of Anti-Tuberculosis Agents
  77. Synthesis, antimalarial, antileishmanial, and antimicrobial activities of some 8-quinolinamine analogues
  78. Advancements in the Anti-Diabetes Chemotherapeutics Based on Amino Acids, Peptides, and Peptidomimetics
  79. Ring-Substituted Imidazoles as a New Class of anti-Tuberculosis Agents.
  80. Facile One-Step Synthesis of N-α-Boc-1-alkyl-L-histidines.
  81. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues
  82. Facile one-step synthesis of N-α-Boc-1-alkyl-l-histidines
  83. Ring-substituted imidazoles as a new class of anti-tuberculosis agents
  84. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1
  85. Ring-substituted quinolines as potential anti-tuberculosis agents
  86. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates
  87. 8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities
  88. Discovery of a Bulky 2- tert -Butyl Group Containing Primaquine Analogue That Exhibits Potent Blood-Schizontocidal Antimalarial Activities and Complete Elimination of Methemoglobin Toxicity
  89. Trityl-Directed Regiospecific Synthesis of 2,3-Disubstituted Bioimidazoles.
  90. 8-Quinolinamines and Their pro prodrug conjugates as potent blood-Schizontocidal antimalarial agents
  91. Substituted 4-Methylquinolines as a New Class of anti-Tuberculosis Agents.
  92. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents
  93. Trityl-Directed Regiospecific Synthesis of 2,3-Disubstituted Bioimidazoles
  94. Antimalarial activities of ring-substituted bioimidazoles
  95. Synthesis and biology of new thyrotropin-Releasing hormone (TRH) analogues
  96. CONVENIENT N-PROTECTION OF L-PYROGLUTAMIC ACID ESTERS
  97. Regiospecific Synthesis of 2,3-Disubstituted-l-Histidines and Histamines
  98. Highly Potent Cyclic Disulfide Antagonists of Somatostatin
  99. Synthesis of ring-halogenated histidines and histamines
  100. Potent Antagonists of Somatostatin:  Synthesis and Biology
  101. Role of the Extracellular Loops of the Thyrotropin-Releasing Hormone Receptor:  Evidence for an Initial Interaction with Thyrotropin-Releasing Hormone †
  102. Synthesis of novel ring-substituted histidines and histamines
  103. Regiospecific alkylation of histidine and histamine at C-2
  104. Regiospecific alkylation of histidine and histamine at N-1 (τ)
  105. Survey of Nonxanthine Derivatives as Adenosine Receptor Ligands
  106. Lactam acetals : Part XXIV reaction with activated haloalkyl compounds with and without zinc
  107. A novel synthesis of di(1-methylazacycloalkeno)[2,3-b:2′,3′-d]pyridines through annulation on lactam acetals
  108. Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist